preclinical studies

Related by string. Preclinical studies * Preclinical : preclinical compounds . preclinical models . preclinical toxicology / STUDIES . Studies : Forced Migration Studies . Graduate Studies * Preclinical studies suggest . Preclinical studies indicate . preclinical studies Nexavar . vivo preclinical studies . preclinical studies Tekmira SNALP . preclinical studies Vion *

Related by context. Frequent words. (Click for all words.) 84 preclinical 73 preclinical models 72 Preclinical studies 69 clinical trials 68 vitro studies 67 Phase Ib 66 RDEA# 65 Preclinical 65 HspE7 65 Phase IIa 65 Phase IIa trial 65 Phase 2a clinical 65 vivo 64 Phase IIa clinical 64 Phase III clinical trials 64 IDX# 64 pharmacokinetic 63 Phase 2a 63 Phase III trials 63 tolerability profile 63 neuroprotective 63 Phase IIb 62 clinical trial 62 bavituximab 62 MGCD# [001] 62 Phase 2b study 62 AEZS 62 antitumor activity 61 Phase 1b 61 anti angiogenic 61 antiviral activity 61 Phase IIb clinical 61 tolerability 61 Phase III clinical 61 AP# [003] 61 APD# 61 investigational compound 61 Phase 2b clinical 61 MGCD# [002] 61 CYT# 61 CUDC 61 AEOL # 60 ADX# 60 small molecule 60 monoclonal antibody 60 TB4 60 investigational drug 60 XL# [003] 60 IMGN# 60 PRX # 60 Phase IIb trial 60 Marqibo 59 perifosine 59 efficacy 59 pharmacokinetic profile 59 MB# [004] 59 immunogenicity 59 RNAi therapeutic 59 picoplatin 59 ARRY 59 MDV# 59 disease modifying 58 elesclomol 58 tivozanib 58 bortezomib 58 siRNA 58 humanized monoclonal antibody 58 PBT2 58 pharmacodynamics 58 pharmacodynamic 58 immunotherapeutic 57 pharmacokinetics 57 RG# [001] 57 clinical 57 Phase 2b 57 CK # 57 NKTR 57 AZD# 56 daclizumab 56 Tovaxin 56 anticancer agents 56 dose escalation study 56 orally administered 56 antisense 56 INCB# [002] 56 carfilzomib 56 investigational 56 laquinimod 56 kinase inhibitors 56 FTY# 55 prodrug 55 antibody 55 oncology indications 55 anticancer 55 vitro 55 pivotal Phase III 55 therapeutic efficacy 55 ALKS 55 monoclonal antibodies 55 XOMA 55 small molecule inhibitor

Back to home page